From bench to byte: A UK perspective on data-driven cancer research

DOI: 10.1016/j.ejca.2026.116751

Overall survival for bevacizumab therapy in metastatic colorectal cancer: an updated analysis of the TRAVASTIN study

DOI: 10.1016/j.clcc.2025.11.001

UpSMART: five years of digital innovation in cancer clinical research—achievements, challenges, and recommendations

DOI: 10.3389/fdgth.2025.1708067

Translating the machine; An assessment of clinician understanding of ophthalmological artificial intelligence outputs

DOI: 10.1016/j.ijmedinf.2025.105958

SylloBio-NLI: Evaluating Large Language Models on Biomedical Syllogistic Reasoning

DOI: 10.18653/v1/2025.naacl-long.371

The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitors 

DOI: 10.1186/s12885-024-13073-0

PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trials

DOI: 10.1177/03008916241248007

Digital ECMT Cancer Trial Matching Tool: an Open Source Research Application to Support Oncologists in the Identification of Precision Medicine Clinical Trials

DOI: 10.1200/CCI.22.00137

Patient attrition in Molecular Tumour Boards: a systematic review

DOI: 10.1038/s41416-022-01922-3

An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves 

DOI: 10.3390/cancers14163931